SitemapContact Us
닫기
Search
Advanced Search +
닫기
Quick links
Most Cited Most Read Ahead of Print Archives Go to E-submission

Original Article

Split Viewer

Blood Res 2018; 53(3):

Published online September 28, 2018

https://doi.org/10.5045/br.2018.53.3.233

© The Korean Society of Hematology

A cross-sectional retrospective study to analyze the underlying causes and clinical characteristics of children with reactive thrombocytosis at a Korean tertiary medical center

Juhee Shin, Dong Hyun Lee, Nani Jung, Hee Joung Choi, and Ye Jee Shim*

Author Info. +

Department of Pediatrics, Keimyung University School of Medicine and Dongsan Medical Center, Daegu, Korea.

Correspondence to : Correspondence to Ye Jee Shim, M.D., Ph.D. Department of Pediatrics, Keimyung University School of Medicine, Dongsan Medical Center, Dalseong-ro 56, Jung-gu, Daegu 41931, Korea. yejeeshim@dsmc.or.kr

Received: April 2, 2018; Revised: June 4, 2018; Accepted: June 26, 2018

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Go to

Background

Reactive thrombocytosis (RT) is a common condition among children, although no studies have examined the etiology or clinical characteristics of RT among Korean children.

Methods

This retrospective study evaluated children with RT at a single Korean tertiary center during a 10-year period.

Results

RT accounted for 13.5% of children who were admitted to the pediatric ward (4,113/30,355): mild RT, 82.7%; moderate RT, 14.1%; severe RT, 1.1%; and extreme RT, 2.1%. There was a negative correlation between platelet count and Hb level (P=0.008). There were positive correlations between platelet count and WBC (P=0.001), erythrocyte sedimentation rate (ESR) (P=0.007), and admission duration (P=0.006). The most common cause of RT was infection and the second most common was Kawasaki disease (KD). The highest proportion of lower respiratory tract infection was observed in extreme RT (P<0.001). The proportion of KD was highest in extreme RT (P<0.001) and in children aged 1–7.9 years (P<0.001). The proportion of refractory KD was highest in extreme RT (P=0.005). In cases of KD, there was a positive correlation between platelet count and fever duration (P=0.006). Non-KD autoimmune inflammation was only observed in mild/moderate RT, and its proportion was highest in children aged 8–18 years (P<0.001).

Conclusion

In children, more severe RT was associated with lower Hb, increased WBC, ESR, and prolonged admission. With respiratory infection or KD, extreme RT was associated with more severe disease course.

Keywords Reactive thrombocytosis, Extreme thrombocytosis, Children, Etiology, Kawasaki disease

INTRODUCTION

Go to

Thrombocytosis is a common condition among children, and it is a frequent cause of referral to a pediatric hemato-oncologist or medical institution for further testing, accounting for 6–15% of hospitalizations and/or visits to an ambulatory/emergency clinic among children [1,2,3]. Thrombocytosis can be classified as primary or reactive thrombocytosis (RT), with primary thrombocytosis involving a primary bone marrow disorder, such as essential thrombocytosis, polycythemia vera, chronic myeloid leukemia, or myelodysplastic syndrome [4]. In contrast, RT is much more frequent than primary thrombocytosis and is caused by non-bone marrow related medical or surgical conditions, which are most often viral or bacterial infections [1,5]. There are national reports regarding the etiology and clinical characteristics of RT among children from several countries [2,6,7,8,9,10,11], although there are no data regarding RT among children in Korea. The present retrospective study aimed to determine the etiology and clinical characteristics of RT among children who were admitted to a single Korean center during a 10-year period, and to compare the results to those from other countries.

MATERIALS AND METHODS

Go to
Participants and ethics statement

In this retrospective study, we collected data for children <18 years old with a platelet count of >500×109/L, who were admitted to the pediatric ward in Keimyung University Dongsan Medical Center between January 2006 to December 2016. We excluded healthy newborns, premature infants who were admitted to the neonatal intensive care unit, and patients with primary thrombocytosis. The study protocol was approved by the institutional review board of Keimyung University Dongsan Medical Center (2017-11-038).

Definitions

Cases of RT were classified based on previous criteria [9,12] as mild (grade 1, platelet count of 501–700, ×109/L), moderate (grade 2, platelet count of 701–900, ×109/L), severe (grade 3, platelet count of 901–1,000, ×109/L), and extreme (grade 4, platelet count of >1,000, ×109/L).

Kawasaki disease (KD) is diagnosed by prolonged fever (≥5 days) and at least four of five clinical features: changes in the extremities, polymorphous exanthema, bilateral bulbar conjunctival injection without exudate, changes in the lips and oral cavity, and cervical lymphadenopathy (>1.5 cm diameter) [13]. According to the American Heart Association, atypical KD is possible in children (≥6 mo) with prolonged fever and two or three principle features or in infants with fever (≥7 days) without other explanation [13]. Refractory KD is defined as persistent fever that lasts for more than 24–36 hours after the end of initial KD treatment [14].

Statistical analysis

Patients' baseline characteristics were reported as median and range, although intragroup comparisons were performed using mean and 95% confidence interval (CI) values. Analysis of variance with Bonferroni adjustment was used to compare mean values between the groups, and intragroup comparisons of proportions were performed using the linear by linear chi-square statistic. Pearson's correlation analysis was performed to define correlations between the variables. All statistical analyses were performed using IBM SPSS version 23.0 (IBM Corp., Armonk, NY, USA), and P-values <0.05 were considered statistically significant.

RESULTS

Go to
Baseline characteristics and underlying causes of RT

Patients' baseline characteristics and underlying causes of RT are described in Table 1. During the study period, RT accounted for 13.5% of children who were admitted to the pediatric ward (4,113/30,355). The median age of children with RT was 0.3 years, and the proportion aged <1 year was 71.0%. Among a total 4,113 children, 82.7% of cases involved mild RT, 14.1% involved moderate RT, 1.1% involved severe RT, and 2.1% of cases involved extreme RT. The most common cause of RT was infection (78.2%) and the second most common cause was KD (6.0%). The characteristics and underlying clinical conditions of the 87 children with extreme RT are described in Table 2. The median age at diagnosis of extreme RT was 0.4 years, and the proportion of children who were <1 year old was 74.7%. The most common cause of extreme RT was infection (67.8%), which most frequently involved respiratory tract infection; the second most common cause of extreme RT was KD (20.7%).

Comparisons according to RT severity

Table 3 shows the variables according to RT severity. Significant differences according to RT severity were detected for hemoglobin (Hb) levels, white blood cell (WBC) count, erythrocyte sedimentation rate (ESR), and admission duration. No significant differences were detected in terms of age, gender ratio, liver function results, C-reactive protein levels, and lactate dehydrogenase levels. Correlation analysis revealed a negative correlation between platelet count and Hb level (r=−0.083, P<0.001), as well as positive correlations between platelet count and WBC count (r=0.145, P<0.001), between platelet count and ESR (r=0.158, P<0.001), and between platelet count and admission duration (r=0.188, P<0.001) (Fig. 1). After controlling for patient age, disease category, liver function, C-reactive protein levels, and lactate dehydrogenase levels, the negative correlation between platelet count and Hb level persisted (r=−0.251, P=0.008). In addition, independent positive correlations persisted between platelet count and WBC count (r=0.305, P=0.001), between platelet count and ESR (r=0.252, P=0.007), and between platelet count and admission duration (r=0.257, P=0.006).

Comparing underlying medical conditions according to RT severity

In cases of respiratory tract infection, the proportions of lower and upper respiratory tract infections were significantly different according to the severity of RT (Table 4). The highest proportion of lower respiratory tract infection was observed in the extreme RT group (P<0.001). In cases of KD, the proportions of RT cases that involved KD were 5.2% (178/3,400) for mild RT, 7.9% (46/580) for moderate RT, 10.9% (5/46) for severe RT, and 20.7% (18/87) for extreme RT (Fig. 2). The differences according to RT severity were significant, and the highest proportion was observed in the extreme RT group (P<0.001). The proportions of refractory KD were significantly different according to RT severity (P=0.005) (Table 4). The proportions of atypical KD were not significantly different according to the RT severity (P=0.319). In cases of children with RT who had KD, correlation analysis revealed a positive correlation between platelet count and fever duration (r=0.175, P=0.006). Non-KD autoimmune inflammation (Henoch-Schönlein purpura, juvenile idiopathic arthritis, Crohn disease, or ulcerative colitis) was not involved in cases of severe or extreme RT, and was limited to mild RT cases (1.4%, 46/3,400) and moderate RT cases (1.7%, 10/580) (Fig. 2).

Age-related distributions of underlying diseases

Children were classified by age into the following groups: children <1 year old, those 1–7.9 years old, and those 8–18 years old. The proportions of KD were 2.6% (77/2,922) in the <1-year-old group, 15.6% (166/1,066) in the 1–7.9-year-old group, and 3.2% (4/124) in the 8–18-year-old group. The proportions of non-KD autoimmune inflammation (Henoch-Schönlein purpura, juvenile idiopathic arthritis, Crohn disease, or ulcerative colitis) were 0% (0/2,922) in the <1-year-old group, 2.4% (26/1,066) in the 1–7.9-year-old group, and 21.8% (27/124) in the 8–18-year-old group. The proportion of KD was significantly higher in the 1–7.9-year-old group and the proportion of autoimmune inflammation was significantly higher in the 8–18-year-old group (both P<0.001) (Fig. 3).

Treatment and clinical outcome of children with RT

Treatment of underlying disorders was performed in participants, and platelet counts gradually decreased after the underlying cause was resolved. Among the 4,113 children, 2.1% of cases had extreme RT. Approximately 40% of children with extreme RT received low-dose acetylsalicylic acid; of these children, over 50% had KD and the remainder did not (Table 2). None of the patients experienced clinical complications (such as thromboembolic events or bleeding) that were associated with extreme RT.

DISCUSSION

Go to

Among the children who were admitted to our center, the prevalence of RT was 13.5% (4,113/30,355), which is similar to the prevalence in other countries [1,2,3]. The incidence of RT is age-dependent, with much higher rates among young children, especially those who are <1–2 years old [2,3,6,7,9,10,11] and much lower rates among children aged >11–15 years [2,3]. In the present study, infants who were <1 year old accounted for >70% of all RT cases. This phenomenon is related to the correlation between serum thrombopoietin (TPO) levels and age-dependent platelet changes [15], with serum TPO levels being highest during the neonatal period and gradually decreasing with age [15]. Despite the prevalence of RT among children, extreme RT is very rare and accounts for approximately 2% of RT cases [3,6], which is similar to the rate in the present study (2.1%, 87/4,331). As previously reported [3], extreme RT was associated with low Hb levels, high WBC counts, and a prolonged admission period. Platelet counts were not correlated with C-reactive protein levels, as has been previously reported [3], although extreme RT was associated with high ESR, and platelet count was positively correlated with ESR in the present study.

Respiratory tract infections are the most common causes of RT and extreme RT [8,10,16], with upper respiratory tract infections being common in cases of mild thrombocytosis and lower respiratory tract infections being common in cases of severe thrombocytosis [8]. In the present study, the highest proportion of lower respiratory tract infection was observed in the extreme RT group. In other words, more severe RT was associated with more severe respiratory tract infection. In the present study, respiratory syncytial virus (RSV) and rhinovirus were the most common pathogens in cases of respiratory tract infection with extreme RT (Table 2), and similar results have been previously reported [17]. Levels of interleukin (IL)-6 or IL-8 can increase during RSV infection [18], which is related to the activation of bronchial epithelial cell secretion and stimulation of platelet production [18].

In this study, KD was the second most common cause of all cases of RT (6.0%, 247/4,113) and extreme RT (20.7%, 18/87). Similarly, KD causes RT in approximately 9.4% of Japanese pediatric cases [2]; these results are markedly higher than those in other countries [6,7,8,9,10,11], which is likely related to the high prevalence of KD in Asian countries, including Korea and Japan [19,20]. Interestingly, the proportions of both KD and refractory KD were highest in the extreme RT subgroup in this study. Further, correlation analysis revealed a positive correlation between platelet count and fever duration in children with KD and RT. In other words, more severe RT was associated with more severe KD.

Thrombocytosis in cases of KD is an important condition, as it increases the risk of coronary aneurysm thrombosis, myocardial infarction, and death [21]. Among patients with KD, RT can be affected by the levels of various cytokines, such as IL-1, IL-6, TPO, and tumor necrosis factor α[21], with TPO being the main cytokine that affects platelet production and megakaryocyte development [21]. The liver and kidneys produce TPO, and serum concentrations are regulated through binding to c-Mpl on platelets and megakaryocytes [22]. Interestingly, TPO levels are usually elevated during the first week of the acute infection phase, with subsequent decreases that correspond to improvement in the symptoms of infection [23,24]. However, platelet counts increase during the second and third weeks of infection [23,24], which may reflect a gradual effect of TPO levels on platelet production through the c-Mpl ligand mechanism [23,24].

In a Japanese study, autoimmune diseases (juvenile idiopathic arthritis, inflammatory bowel diseases, and KD) accounted for 4–11% of pediatric RT cases [2], with KD being the principal cause of RT among children <7 years old and other diseases being the main causes among those aged >11 years [2]. In the present study, the cause of RT was classified as KD or non-KD autoimmune inflammation, which included Henoch-Schönlein purpura, juvenile idiopathic arthritis, and inflammatory bowel diseases. Similar to the findings of the Japanese study [2], the present study revealed that the proportion of KD was highest in the 1–7.9-year-old group and the proportion of non-KD autoimmune inflammation was highest in the 8–18-year-old group (P<0.001).

In most cases, RT is benign and the platelet count is normalized after treatment of the primary disease, in the absence of complications [10,25]. Furthermore, most patients with RT do not require prophylactic treatment using anticoagulants or platelet aggregation inhibitors [12]. Even in extreme cases of RT, there is no established prophylactic treatment or evidence to support the use of prophylactic drugs for asymptomatic children [12]. Thus, if thrombocytosis persists after treatment of RT that is based on the underlying etiology of RT, treatment can be considered for thrombocytosis [25].

There are some limitations in our study. Most patients with RT did not undergo blood testing until platelet counts had dropped to completely normal levels. Therefore, the exact duration of the platelet increase could not be calculated and was insufficient to be included as statistical data.

In conclusion, infection, especially respiratory tract infection, was the most common cause of RT among Korean children in this study, and KD was the second most common cause. Extreme RT was associated with leukocytosis, anemia, increased ESR, prolonged admission duration, more severe respiratory tract infection, and more severe KD. Therefore, RT could be a factor in evaluating the severity of disease and predicting hospitalization duration. In addition, the present study revealed that KD was an important cause of extreme RT and all RT among 1–7.9-year-old patients, whereas non-KD autoimmune inflammation was more likely to cause mild-to-moderate RT, especially among children ≥8 years old. However, the present study is limited by its single-center design, and further evaluation is needed to better understand the status of RT in Korea.

FIGURES

Go to
Fig. 1.

Correlation analysis revealed a negative correlation between platelet count and hemoglobin level (A), as well as positive correlations between platelet count and white blood cell count (B), between platelet count and erythrocyte sedimentation rate (C), and between platelet count and admission duration (D).


Fig. 2.

The proportion of Kawasaki disease (navy arrow) according to the severity of reactive thrombocytosis (RT) among children who were admitted to a single Korean tertiary center. The proportion of Kawasaki disease was significantly different between the groups by reactive thrombocytosis severity, with the highest proportion in the extreme RT group (P<0.001).


Fig. 3.

The proportions of Kawasaki disease (navy arrow) and autoimmune inflammation (white arrow with black outline) according to patient age. The proportion of Kawasaki disease was highest in the 1–7.9-year-old group, and the proportion of inflammation was highest in the 8–18-year-old group (P<0.001). Autoimmune inflammation includes Henoch-Schönlein purpura, juvenile idiopathic arthritis, Crohn disease, and ulcerative colitis.


TABLES

Go to
Table. 1.Baseline characteristics and underlying causes reactive thrombocytosis in 4,113 children.

a)Autoimmune inflammation was classified separately from Kawasaki disease. b)Congenital malformation includes hypertrophic pyloric stenosis, Hirschsprung disease, biliary atresia, choledochal cyst, congenital hydronephrosis, imperforate anus, and tracheoesophageal fistula.
Table. 2.Baseline characteristics of 87 children with extreme reactive thrombocytosis.
Table. 3.Comparison of variables according to the severity of reactive thrombocytosis.

Values are presented as mean and 95% confidence intervals.

Abbreviations: ALT, alanine transaminase; AST, aspartate transaminase; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; LDH, lactate dehydrogenase.
Table. 4.Comparison of the proportions of lower and upper respiratory infections, and refractory and atypical Kawasaki disease, according to the severity of reactive thrombocytosis.

REFERENCES

Go to
  1. Mantadakis E, Tsalkidis A, Chatzimichael A. Thrombocytosis in childhood. Indian Pediatr 2008;45:669-677.
    Pubmed
  2. Matsubara K, Fukaya T, Nigami H, et al. Age-dependent changes in the incidence and etiology of childhood thrombocytosis. Acta Haematol 2004;111:132-137.
    Pubmed
  3. Wang JL, Huang LT, Wu KH, Lin HW, Ho MY, Liu HE. Associations of reactive thrombocytosis with clinical characteristics in pediatric diseases. Pediatr Neonatol 2011;52:261-266.
    Pubmed
  4. Sanchez S, Ewton A. Essential thrombocythemia: a review of diagnostic and pathologic features. Arch Pathol Lab Med 2006;130:1144-1150.
    Pubmed
  5. Kucine N, Chastain KM, Mahler MB, Bussel JB. Primary thrombocytosis in children. Haematologica 2014;99:620-628.
    Pubmed
  6. Demidowicz E, Moppert J, Nowacka AZ, Styczynski J, Wysocki M. Essential thrombocythemia and reactive thrombocytosis in children. EC Paediatrics 2016;2:107-115.
  7. Heng JT, Tan AM. Thrombocytosis in childhood. Singapore Med J 1998;39:485-487.
    Pubmed
  8. Özcan C, Şaylı TR, Koşan-Çulha V. Reactive thrombocytosis in children. Turk J Pediatr 2013;55:411-416.
    Pubmed
  9. Sutor AH. Thrombocytosis in childhood. Semin Thromb Hemost 1995;21:330-339.
    Pubmed
  10. Vora AJ, Lilleyman JS. Secondary thrombocytosis. Arch Dis Child 1993;68:88-90.
    Pubmed
  11. Yohannan MD, Higgy KE, al-Mashhadani SA, Santhosh-Kumar CR. Thrombocytosis. Etiologic analysis of 663 patients. Clin Pediatr (Phila) 1994;33:340-343.
    Pubmed
  12. Dame C, Sutor AH. Primary and secondary thrombocytosis in childhood. Br J Haematol 2005;129:165-177.
    Pubmed
  13. McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 2017;135:e927-e999.
    Pubmed
  14. Kim HJ, Lee HE, Yu JW, Kil HR. Clinical outcome of patients with refractory Kawasaki disease based on treatment modalities. Korean J Pediatr 2016;59:328-334.
    Pubmed
  15. Ishiguro A, Nakahata T, Matsubara K, et al. Age-related changes in thrombopoietin in children: reference interval for serum thrombopoietin levels. Br J Haematol 1999;106:884-888.
    Pubmed
  16. O'Shea J, Sherlock M, Philip R. Thrombocytosis in childhood. Acta Haematol 2005;113:212.
    Pubmed
  17. Zheng SY, Xiao QY, Xie XH, et al. Association between secondary thrombocytosis and viral respiratory tract infections in children. Sci Rep 2016;6:22964.
    Pubmed
  18. Lee FE, Walsh EE, Falsey AR, et al. Human infant respiratory syncytial virus (RSV)-specific type 1 and 2 cytokine responses ex vivo during primary RSV infection. J Infect Dis 2007;195:1779-1788.
    Pubmed
  19. Park YW, Han JW, Park IS, et al. Kawasaki disease in Korea, 2003–2005. Pediatr Infect Dis J 2007;26:821-823.
    Pubmed
  20. Newburger JW, Taubert KA, Shulman ST, et al. Summary and abstracts of the Seventh International Kawasaki Disease Symposium: December 4–7, 2001, Hakone, Japan. Pediatr Res 2003;53:153-157.
    Pubmed
  21. Emmons RV, Reid DM, Cohen RL, et al. Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood 1996;87:4068-4071.
    Pubmed
  22. Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood 1995;86:419-431.
    Pubmed
  23. Ishiguro A, Ishikita T, Shimbo T, et al. Elevation of serum thrombopoietin precedes thrombocytosis in Kawasaki disease. Thromb Haemost 1998;79:1096-1100.
    Pubmed
  24. Ishiguro A, Suzuki Y, Mito M, et al. Elevation of serum thrombopoietin precedes thrombocytosis in acute infections. Br J Haematol 2002;116:612-618.
    Pubmed
  25. Sutor AH. Screening children with thrombosis for thrombophilic proteins. Cui bono?. J Thromb Haemost 2003;1:886-888.
    Pubmed

Article

Original Article

Blood Res 2018; 53(3): 233-239

Published online September 28, 2018 https://doi.org/10.5045/br.2018.53.3.233

Copyright © The Korean Society of Hematology.

A cross-sectional retrospective study to analyze the underlying causes and clinical characteristics of children with reactive thrombocytosis at a Korean tertiary medical center

Juhee Shin, Dong Hyun Lee, Nani Jung, Hee Joung Choi, and Ye Jee Shim*

Department of Pediatrics, Keimyung University School of Medicine and Dongsan Medical Center, Daegu, Korea.

Correspondence to: Correspondence to Ye Jee Shim, M.D., Ph.D. Department of Pediatrics, Keimyung University School of Medicine, Dongsan Medical Center, Dalseong-ro 56, Jung-gu, Daegu 41931, Korea. yejeeshim@dsmc.or.kr

Received: April 2, 2018; Revised: June 4, 2018; Accepted: June 26, 2018

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

Reactive thrombocytosis (RT) is a common condition among children, although no studies have examined the etiology or clinical characteristics of RT among Korean children.

Methods

This retrospective study evaluated children with RT at a single Korean tertiary center during a 10-year period.

Results

RT accounted for 13.5% of children who were admitted to the pediatric ward (4,113/30,355): mild RT, 82.7%; moderate RT, 14.1%; severe RT, 1.1%; and extreme RT, 2.1%. There was a negative correlation between platelet count and Hb level (P=0.008). There were positive correlations between platelet count and WBC (P=0.001), erythrocyte sedimentation rate (ESR) (P=0.007), and admission duration (P=0.006). The most common cause of RT was infection and the second most common was Kawasaki disease (KD). The highest proportion of lower respiratory tract infection was observed in extreme RT (P<0.001). The proportion of KD was highest in extreme RT (P<0.001) and in children aged 1–7.9 years (P<0.001). The proportion of refractory KD was highest in extreme RT (P=0.005). In cases of KD, there was a positive correlation between platelet count and fever duration (P=0.006). Non-KD autoimmune inflammation was only observed in mild/moderate RT, and its proportion was highest in children aged 8–18 years (P<0.001).

Conclusion

In children, more severe RT was associated with lower Hb, increased WBC, ESR, and prolonged admission. With respiratory infection or KD, extreme RT was associated with more severe disease course.

Keywords: Reactive thrombocytosis, Extreme thrombocytosis, Children, Etiology, Kawasaki disease

INTRODUCTION

Thrombocytosis is a common condition among children, and it is a frequent cause of referral to a pediatric hemato-oncologist or medical institution for further testing, accounting for 6–15% of hospitalizations and/or visits to an ambulatory/emergency clinic among children [1,2,3]. Thrombocytosis can be classified as primary or reactive thrombocytosis (RT), with primary thrombocytosis involving a primary bone marrow disorder, such as essential thrombocytosis, polycythemia vera, chronic myeloid leukemia, or myelodysplastic syndrome [4]. In contrast, RT is much more frequent than primary thrombocytosis and is caused by non-bone marrow related medical or surgical conditions, which are most often viral or bacterial infections [1,5]. There are national reports regarding the etiology and clinical characteristics of RT among children from several countries [2,6,7,8,9,10,11], although there are no data regarding RT among children in Korea. The present retrospective study aimed to determine the etiology and clinical characteristics of RT among children who were admitted to a single Korean center during a 10-year period, and to compare the results to those from other countries.

MATERIALS AND METHODS

Participants and ethics statement

In this retrospective study, we collected data for children <18 years old with a platelet count of >500×109/L, who were admitted to the pediatric ward in Keimyung University Dongsan Medical Center between January 2006 to December 2016. We excluded healthy newborns, premature infants who were admitted to the neonatal intensive care unit, and patients with primary thrombocytosis. The study protocol was approved by the institutional review board of Keimyung University Dongsan Medical Center (2017-11-038).

Definitions

Cases of RT were classified based on previous criteria [9,12] as mild (grade 1, platelet count of 501–700, ×109/L), moderate (grade 2, platelet count of 701–900, ×109/L), severe (grade 3, platelet count of 901–1,000, ×109/L), and extreme (grade 4, platelet count of >1,000, ×109/L).

Kawasaki disease (KD) is diagnosed by prolonged fever (≥5 days) and at least four of five clinical features: changes in the extremities, polymorphous exanthema, bilateral bulbar conjunctival injection without exudate, changes in the lips and oral cavity, and cervical lymphadenopathy (>1.5 cm diameter) [13]. According to the American Heart Association, atypical KD is possible in children (≥6 mo) with prolonged fever and two or three principle features or in infants with fever (≥7 days) without other explanation [13]. Refractory KD is defined as persistent fever that lasts for more than 24–36 hours after the end of initial KD treatment [14].

Statistical analysis

Patients' baseline characteristics were reported as median and range, although intragroup comparisons were performed using mean and 95% confidence interval (CI) values. Analysis of variance with Bonferroni adjustment was used to compare mean values between the groups, and intragroup comparisons of proportions were performed using the linear by linear chi-square statistic. Pearson's correlation analysis was performed to define correlations between the variables. All statistical analyses were performed using IBM SPSS version 23.0 (IBM Corp., Armonk, NY, USA), and P-values <0.05 were considered statistically significant.

RESULTS

Baseline characteristics and underlying causes of RT

Patients' baseline characteristics and underlying causes of RT are described in Table 1. During the study period, RT accounted for 13.5% of children who were admitted to the pediatric ward (4,113/30,355). The median age of children with RT was 0.3 years, and the proportion aged <1 year was 71.0%. Among a total 4,113 children, 82.7% of cases involved mild RT, 14.1% involved moderate RT, 1.1% involved severe RT, and 2.1% of cases involved extreme RT. The most common cause of RT was infection (78.2%) and the second most common cause was KD (6.0%). The characteristics and underlying clinical conditions of the 87 children with extreme RT are described in Table 2. The median age at diagnosis of extreme RT was 0.4 years, and the proportion of children who were <1 year old was 74.7%. The most common cause of extreme RT was infection (67.8%), which most frequently involved respiratory tract infection; the second most common cause of extreme RT was KD (20.7%).

Comparisons according to RT severity

Table 3 shows the variables according to RT severity. Significant differences according to RT severity were detected for hemoglobin (Hb) levels, white blood cell (WBC) count, erythrocyte sedimentation rate (ESR), and admission duration. No significant differences were detected in terms of age, gender ratio, liver function results, C-reactive protein levels, and lactate dehydrogenase levels. Correlation analysis revealed a negative correlation between platelet count and Hb level (r=−0.083, P<0.001), as well as positive correlations between platelet count and WBC count (r=0.145, P<0.001), between platelet count and ESR (r=0.158, P<0.001), and between platelet count and admission duration (r=0.188, P<0.001) (Fig. 1). After controlling for patient age, disease category, liver function, C-reactive protein levels, and lactate dehydrogenase levels, the negative correlation between platelet count and Hb level persisted (r=−0.251, P=0.008). In addition, independent positive correlations persisted between platelet count and WBC count (r=0.305, P=0.001), between platelet count and ESR (r=0.252, P=0.007), and between platelet count and admission duration (r=0.257, P=0.006).

Comparing underlying medical conditions according to RT severity

In cases of respiratory tract infection, the proportions of lower and upper respiratory tract infections were significantly different according to the severity of RT (Table 4). The highest proportion of lower respiratory tract infection was observed in the extreme RT group (P<0.001). In cases of KD, the proportions of RT cases that involved KD were 5.2% (178/3,400) for mild RT, 7.9% (46/580) for moderate RT, 10.9% (5/46) for severe RT, and 20.7% (18/87) for extreme RT (Fig. 2). The differences according to RT severity were significant, and the highest proportion was observed in the extreme RT group (P<0.001). The proportions of refractory KD were significantly different according to RT severity (P=0.005) (Table 4). The proportions of atypical KD were not significantly different according to the RT severity (P=0.319). In cases of children with RT who had KD, correlation analysis revealed a positive correlation between platelet count and fever duration (r=0.175, P=0.006). Non-KD autoimmune inflammation (Henoch-Schönlein purpura, juvenile idiopathic arthritis, Crohn disease, or ulcerative colitis) was not involved in cases of severe or extreme RT, and was limited to mild RT cases (1.4%, 46/3,400) and moderate RT cases (1.7%, 10/580) (Fig. 2).

Age-related distributions of underlying diseases

Children were classified by age into the following groups: children <1 year old, those 1–7.9 years old, and those 8–18 years old. The proportions of KD were 2.6% (77/2,922) in the <1-year-old group, 15.6% (166/1,066) in the 1–7.9-year-old group, and 3.2% (4/124) in the 8–18-year-old group. The proportions of non-KD autoimmune inflammation (Henoch-Schönlein purpura, juvenile idiopathic arthritis, Crohn disease, or ulcerative colitis) were 0% (0/2,922) in the <1-year-old group, 2.4% (26/1,066) in the 1–7.9-year-old group, and 21.8% (27/124) in the 8–18-year-old group. The proportion of KD was significantly higher in the 1–7.9-year-old group and the proportion of autoimmune inflammation was significantly higher in the 8–18-year-old group (both P<0.001) (Fig. 3).

Treatment and clinical outcome of children with RT

Treatment of underlying disorders was performed in participants, and platelet counts gradually decreased after the underlying cause was resolved. Among the 4,113 children, 2.1% of cases had extreme RT. Approximately 40% of children with extreme RT received low-dose acetylsalicylic acid; of these children, over 50% had KD and the remainder did not (Table 2). None of the patients experienced clinical complications (such as thromboembolic events or bleeding) that were associated with extreme RT.

DISCUSSION

Among the children who were admitted to our center, the prevalence of RT was 13.5% (4,113/30,355), which is similar to the prevalence in other countries [1,2,3]. The incidence of RT is age-dependent, with much higher rates among young children, especially those who are <1–2 years old [2,3,6,7,9,10,11] and much lower rates among children aged >11–15 years [2,3]. In the present study, infants who were <1 year old accounted for >70% of all RT cases. This phenomenon is related to the correlation between serum thrombopoietin (TPO) levels and age-dependent platelet changes [15], with serum TPO levels being highest during the neonatal period and gradually decreasing with age [15]. Despite the prevalence of RT among children, extreme RT is very rare and accounts for approximately 2% of RT cases [3,6], which is similar to the rate in the present study (2.1%, 87/4,331). As previously reported [3], extreme RT was associated with low Hb levels, high WBC counts, and a prolonged admission period. Platelet counts were not correlated with C-reactive protein levels, as has been previously reported [3], although extreme RT was associated with high ESR, and platelet count was positively correlated with ESR in the present study.

Respiratory tract infections are the most common causes of RT and extreme RT [8,10,16], with upper respiratory tract infections being common in cases of mild thrombocytosis and lower respiratory tract infections being common in cases of severe thrombocytosis [8]. In the present study, the highest proportion of lower respiratory tract infection was observed in the extreme RT group. In other words, more severe RT was associated with more severe respiratory tract infection. In the present study, respiratory syncytial virus (RSV) and rhinovirus were the most common pathogens in cases of respiratory tract infection with extreme RT (Table 2), and similar results have been previously reported [17]. Levels of interleukin (IL)-6 or IL-8 can increase during RSV infection [18], which is related to the activation of bronchial epithelial cell secretion and stimulation of platelet production [18].

In this study, KD was the second most common cause of all cases of RT (6.0%, 247/4,113) and extreme RT (20.7%, 18/87). Similarly, KD causes RT in approximately 9.4% of Japanese pediatric cases [2]; these results are markedly higher than those in other countries [6,7,8,9,10,11], which is likely related to the high prevalence of KD in Asian countries, including Korea and Japan [19,20]. Interestingly, the proportions of both KD and refractory KD were highest in the extreme RT subgroup in this study. Further, correlation analysis revealed a positive correlation between platelet count and fever duration in children with KD and RT. In other words, more severe RT was associated with more severe KD.

Thrombocytosis in cases of KD is an important condition, as it increases the risk of coronary aneurysm thrombosis, myocardial infarction, and death [21]. Among patients with KD, RT can be affected by the levels of various cytokines, such as IL-1, IL-6, TPO, and tumor necrosis factor α[21], with TPO being the main cytokine that affects platelet production and megakaryocyte development [21]. The liver and kidneys produce TPO, and serum concentrations are regulated through binding to c-Mpl on platelets and megakaryocytes [22]. Interestingly, TPO levels are usually elevated during the first week of the acute infection phase, with subsequent decreases that correspond to improvement in the symptoms of infection [23,24]. However, platelet counts increase during the second and third weeks of infection [23,24], which may reflect a gradual effect of TPO levels on platelet production through the c-Mpl ligand mechanism [23,24].

In a Japanese study, autoimmune diseases (juvenile idiopathic arthritis, inflammatory bowel diseases, and KD) accounted for 4–11% of pediatric RT cases [2], with KD being the principal cause of RT among children <7 years old and other diseases being the main causes among those aged >11 years [2]. In the present study, the cause of RT was classified as KD or non-KD autoimmune inflammation, which included Henoch-Schönlein purpura, juvenile idiopathic arthritis, and inflammatory bowel diseases. Similar to the findings of the Japanese study [2], the present study revealed that the proportion of KD was highest in the 1–7.9-year-old group and the proportion of non-KD autoimmune inflammation was highest in the 8–18-year-old group (P<0.001).

In most cases, RT is benign and the platelet count is normalized after treatment of the primary disease, in the absence of complications [10,25]. Furthermore, most patients with RT do not require prophylactic treatment using anticoagulants or platelet aggregation inhibitors [12]. Even in extreme cases of RT, there is no established prophylactic treatment or evidence to support the use of prophylactic drugs for asymptomatic children [12]. Thus, if thrombocytosis persists after treatment of RT that is based on the underlying etiology of RT, treatment can be considered for thrombocytosis [25].

There are some limitations in our study. Most patients with RT did not undergo blood testing until platelet counts had dropped to completely normal levels. Therefore, the exact duration of the platelet increase could not be calculated and was insufficient to be included as statistical data.

In conclusion, infection, especially respiratory tract infection, was the most common cause of RT among Korean children in this study, and KD was the second most common cause. Extreme RT was associated with leukocytosis, anemia, increased ESR, prolonged admission duration, more severe respiratory tract infection, and more severe KD. Therefore, RT could be a factor in evaluating the severity of disease and predicting hospitalization duration. In addition, the present study revealed that KD was an important cause of extreme RT and all RT among 1–7.9-year-old patients, whereas non-KD autoimmune inflammation was more likely to cause mild-to-moderate RT, especially among children ≥8 years old. However, the present study is limited by its single-center design, and further evaluation is needed to better understand the status of RT in Korea.

Fig 1.

Download
Figure 1.

Correlation analysis revealed a negative correlation between platelet count and hemoglobin level (A), as well as positive correlations between platelet count and white blood cell count (B), between platelet count and erythrocyte sedimentation rate (C), and between platelet count and admission duration (D).

Blood Research 2018; 53: 233-239https://doi.org/10.5045/br.2018.53.3.233

Fig 2.

Download
Figure 2.

The proportion of Kawasaki disease (navy arrow) according to the severity of reactive thrombocytosis (RT) among children who were admitted to a single Korean tertiary center. The proportion of Kawasaki disease was significantly different between the groups by reactive thrombocytosis severity, with the highest proportion in the extreme RT group (P<0.001).

Blood Research 2018; 53: 233-239https://doi.org/10.5045/br.2018.53.3.233

Fig 3.

Download
Figure 3.

The proportions of Kawasaki disease (navy arrow) and autoimmune inflammation (white arrow with black outline) according to patient age. The proportion of Kawasaki disease was highest in the 1–7.9-year-old group, and the proportion of inflammation was highest in the 8–18-year-old group (P<0.001). Autoimmune inflammation includes Henoch-Schönlein purpura, juvenile idiopathic arthritis, Crohn disease, and ulcerative colitis.

Blood Research 2018; 53: 233-239https://doi.org/10.5045/br.2018.53.3.233
Baseline characteristics and underlying causes reactive thrombocytosis in 4,113 children.

a)Autoimmune inflammation was classified separately from Kawasaki disease. b)Congenital malformation includes hypertrophic pyloric stenosis, Hirschsprung disease, biliary atresia, choledochal cyst, congenital hydronephrosis, imperforate anus, and tracheoesophageal fistula..
Baseline characteristics of 87 children with extreme reactive thrombocytosis.
Comparison of variables according to the severity of reactive thrombocytosis.

Values are presented as mean and 95% confidence intervals..

Abbreviations: ALT, alanine transaminase; AST, aspartate transaminase; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; LDH, lactate dehydrogenase..
Comparison of the proportions of lower and upper respiratory infections, and refractory and atypical Kawasaki disease, according to the severity of reactive thrombocytosis.

References

  1. Mantadakis E, Tsalkidis A, Chatzimichael A. Thrombocytosis in childhood. Indian Pediatr 2008;45:669-677.
    Pubmed
  2. Matsubara K, Fukaya T, Nigami H, et al. Age-dependent changes in the incidence and etiology of childhood thrombocytosis. Acta Haematol 2004;111:132-137.
    Pubmed
  3. Wang JL, Huang LT, Wu KH, Lin HW, Ho MY, Liu HE. Associations of reactive thrombocytosis with clinical characteristics in pediatric diseases. Pediatr Neonatol 2011;52:261-266.
    Pubmed
  4. Sanchez S, Ewton A. Essential thrombocythemia: a review of diagnostic and pathologic features. Arch Pathol Lab Med 2006;130:1144-1150.
    Pubmed
  5. Kucine N, Chastain KM, Mahler MB, Bussel JB. Primary thrombocytosis in children. Haematologica 2014;99:620-628.
    Pubmed
  6. Demidowicz E, Moppert J, Nowacka AZ, Styczynski J, Wysocki M. Essential thrombocythemia and reactive thrombocytosis in children. EC Paediatrics 2016;2:107-115.
  7. Heng JT, Tan AM. Thrombocytosis in childhood. Singapore Med J 1998;39:485-487.
    Pubmed
  8. Özcan C, Şaylı TR, Koşan-Çulha V. Reactive thrombocytosis in children. Turk J Pediatr 2013;55:411-416.
    Pubmed
  9. Sutor AH. Thrombocytosis in childhood. Semin Thromb Hemost 1995;21:330-339.
    Pubmed
  10. Vora AJ, Lilleyman JS. Secondary thrombocytosis. Arch Dis Child 1993;68:88-90.
    Pubmed
  11. Yohannan MD, Higgy KE, al-Mashhadani SA, Santhosh-Kumar CR. Thrombocytosis. Etiologic analysis of 663 patients. Clin Pediatr (Phila) 1994;33:340-343.
    Pubmed
  12. Dame C, Sutor AH. Primary and secondary thrombocytosis in childhood. Br J Haematol 2005;129:165-177.
    Pubmed
  13. McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 2017;135:e927-e999.
    Pubmed
  14. Kim HJ, Lee HE, Yu JW, Kil HR. Clinical outcome of patients with refractory Kawasaki disease based on treatment modalities. Korean J Pediatr 2016;59:328-334.
    Pubmed
  15. Ishiguro A, Nakahata T, Matsubara K, et al. Age-related changes in thrombopoietin in children: reference interval for serum thrombopoietin levels. Br J Haematol 1999;106:884-888.
    Pubmed
  16. O'Shea J, Sherlock M, Philip R. Thrombocytosis in childhood. Acta Haematol 2005;113:212.
    Pubmed
  17. Zheng SY, Xiao QY, Xie XH, et al. Association between secondary thrombocytosis and viral respiratory tract infections in children. Sci Rep 2016;6:22964.
    Pubmed
  18. Lee FE, Walsh EE, Falsey AR, et al. Human infant respiratory syncytial virus (RSV)-specific type 1 and 2 cytokine responses ex vivo during primary RSV infection. J Infect Dis 2007;195:1779-1788.
    Pubmed
  19. Park YW, Han JW, Park IS, et al. Kawasaki disease in Korea, 2003–2005. Pediatr Infect Dis J 2007;26:821-823.
    Pubmed
  20. Newburger JW, Taubert KA, Shulman ST, et al. Summary and abstracts of the Seventh International Kawasaki Disease Symposium: December 4–7, 2001, Hakone, Japan. Pediatr Res 2003;53:153-157.
    Pubmed
  21. Emmons RV, Reid DM, Cohen RL, et al. Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood 1996;87:4068-4071.
    Pubmed
  22. Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood 1995;86:419-431.
    Pubmed
  23. Ishiguro A, Ishikita T, Shimbo T, et al. Elevation of serum thrombopoietin precedes thrombocytosis in Kawasaki disease. Thromb Haemost 1998;79:1096-1100.
    Pubmed
  24. Ishiguro A, Suzuki Y, Mito M, et al. Elevation of serum thrombopoietin precedes thrombocytosis in acute infections. Br J Haematol 2002;116:612-618.
    Pubmed
  25. Sutor AH. Screening children with thrombosis for thrombophilic proteins. Cui bono?. J Thromb Haemost 2003;1:886-888.
    Pubmed
Blood Res
Volume 59 2024
Current Issue Archives

Stats or Metrics

Share this article on

  • line

Related articles in BR

Blood Research

pISSN 2287-979X
eISSN 2288-0011
qr-code Download